Compounds > pomalidomide
Page last updated: 2024-09-04

pomalidomide and Cirrhosis

pomalidomide has been researched along with Cirrhosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choi, S; Cooper, A; Denton, CP; Distler, JHW; Domsic, RT; Furst, DE; Horan, G; Hough, DR; Hsu, VM; Korish, S; Rischmueller, M; Schafer, PH; Stanislav, M; Steen, VD1
Beyer, C; Cedzik, D; Dees, C; Distler, A; Distler, JH; Distler, O; Palumbo-Zerr, K; Schafer, PH; Schett, G; Shankar, SL; Tomcik, M; Weingärtner, S; Zerr, P1

Trials

1 trial(s) available for pomalidomide and Cirrhosis

ArticleYear
Pomalidomide in Patients with Interstitial Lung Disease due to Systemic Sclerosis: A Phase II, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study.
    The Journal of rheumatology, 2018, Volume: 45, Issue:3

    Topics: Adult; Double-Blind Method; Early Termination of Clinical Trials; Female; Fibrosis; Follow-Up Studies; Forced Expiratory Volume; Humans; Immunologic Factors; Lung; Lung Diseases, Interstitial; Male; Middle Aged; Scleroderma, Systemic; Skin; Thalidomide; Treatment Outcome; Vital Capacity

2018

Other Studies

1 other study(ies) available for pomalidomide and Cirrhosis

ArticleYear
Pomalidomide is effective for prevention and treatment of experimental skin fibrosis.
    Annals of the rheumatic diseases, 2012, Volume: 71, Issue:11

    Topics: Animals; Disease Models, Animal; Fibrosis; Hydroxyproline; Immunosuppressive Agents; Mice; Mice, Inbred DBA; Mice, Mutant Strains; Myofibroblasts; Skin; Skin Diseases; Thalidomide

2012